A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU2F2
|
ENSG00000028277.16 | POU class 2 homeobox 2 |
POU3F1
|
ENSG00000185668.5 | POU class 3 homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU2F2 | hg19_v2_chr19_-_42636543_42636607 | -0.52 | 4.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_26183958 | 5.63 |
ENST00000356530.3
|
HIST1H2BE
|
histone cluster 1, H2be |
chr6_+_27114861 | 4.03 |
ENST00000377459.1
|
HIST1H2AH
|
histone cluster 1, H2ah |
chr6_-_26033796 | 3.77 |
ENST00000259791.2
|
HIST1H2AB
|
histone cluster 1, H2ab |
chr6_+_27782788 | 3.46 |
ENST00000359465.4
|
HIST1H2BM
|
histone cluster 1, H2bm |
chr6_-_27860956 | 3.40 |
ENST00000359611.2
|
HIST1H2AM
|
histone cluster 1, H2am |
chr6_-_26043885 | 3.40 |
ENST00000357905.2
|
HIST1H2BB
|
histone cluster 1, H2bb |
chr1_+_228645796 | 3.35 |
ENST00000369160.2
|
HIST3H2BB
|
histone cluster 3, H2bb |
chr6_-_27782548 | 2.86 |
ENST00000333151.3
|
HIST1H2AJ
|
histone cluster 1, H2aj |
chr1_+_149822620 | 2.69 |
ENST00000369159.2
|
HIST2H2AA4
|
histone cluster 2, H2aa4 |
chr1_-_149783914 | 2.69 |
ENST00000369167.1
ENST00000427880.2 ENST00000545683.1 |
HIST2H2BF
|
histone cluster 2, H2bf |
chr6_+_27861190 | 2.60 |
ENST00000303806.4
|
HIST1H2BO
|
histone cluster 1, H2bo |
chr1_+_149858461 | 2.51 |
ENST00000331380.2
|
HIST2H2AC
|
histone cluster 2, H2ac |
chr9_-_35658007 | 2.29 |
ENST00000602361.1
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease |
chr6_+_26273144 | 2.09 |
ENST00000377733.2
|
HIST1H2BI
|
histone cluster 1, H2bi |
chr1_-_228645556 | 1.90 |
ENST00000366695.2
|
HIST3H2A
|
histone cluster 3, H2a |
chr17_+_19091325 | 1.82 |
ENST00000584923.1
|
SNORD3A
|
small nucleolar RNA, C/D box 3A |
chr7_-_27153454 | 1.71 |
ENST00000522456.1
|
HOXA3
|
homeobox A3 |
chr1_-_149814478 | 1.66 |
ENST00000369161.3
|
HIST2H2AA3
|
histone cluster 2, H2aa3 |
chr6_-_26124138 | 1.64 |
ENST00000314332.5
ENST00000396984.1 |
HIST1H2BC
|
histone cluster 1, H2bc |
chr6_+_31588478 | 1.61 |
ENST00000376007.4
ENST00000376033.2 |
PRRC2A
|
proline-rich coiled-coil 2A |
chr19_-_44124019 | 1.49 |
ENST00000300811.3
|
ZNF428
|
zinc finger protein 428 |
chr17_-_19651598 | 1.47 |
ENST00000570414.1
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr1_+_201979743 | 1.38 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr12_+_7052974 | 1.34 |
ENST00000544681.1
ENST00000537087.1 |
C12orf57
|
chromosome 12 open reading frame 57 |
chr6_+_26251835 | 1.27 |
ENST00000356350.2
|
HIST1H2BH
|
histone cluster 1, H2bh |
chr6_-_27775694 | 1.25 |
ENST00000377401.2
|
HIST1H2BL
|
histone cluster 1, H2bl |
chr6_-_26216872 | 1.20 |
ENST00000244601.3
|
HIST1H2BG
|
histone cluster 1, H2bg |
chr12_+_122064398 | 1.14 |
ENST00000330079.7
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
chr6_-_27100529 | 1.07 |
ENST00000607124.1
ENST00000339812.2 ENST00000541790.1 |
HIST1H2BJ
|
histone cluster 1, H2bj |
chr6_+_27775899 | 1.02 |
ENST00000358739.3
|
HIST1H2AI
|
histone cluster 1, H2ai |
chr19_+_41305330 | 0.99 |
ENST00000593972.1
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
chr2_-_207082748 | 0.99 |
ENST00000407325.2
ENST00000411719.1 |
GPR1
|
G protein-coupled receptor 1 |
chr19_+_56111680 | 0.97 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
chr1_-_149859466 | 0.97 |
ENST00000331128.3
|
HIST2H2AB
|
histone cluster 2, H2ab |
chr7_-_44122063 | 0.94 |
ENST00000335195.6
ENST00000395831.3 ENST00000414235.1 ENST00000452049.1 ENST00000242248.5 |
POLM
|
polymerase (DNA directed), mu |
chr2_-_239148599 | 0.93 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
chr8_-_33370607 | 0.93 |
ENST00000360742.5
ENST00000523305.1 |
TTI2
|
TELO2 interacting protein 2 |
chr12_-_11214893 | 0.90 |
ENST00000533467.1
|
TAS2R46
|
taste receptor, type 2, member 46 |
chr17_-_19015945 | 0.89 |
ENST00000573866.2
|
SNORD3D
|
small nucleolar RNA, C/D box 3D |
chr19_+_17337027 | 0.85 |
ENST00000601529.1
ENST00000600232.1 |
OCEL1
|
occludin/ELL domain containing 1 |
chr9_+_136325089 | 0.85 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr6_+_37137939 | 0.84 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr17_-_7307358 | 0.82 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr19_-_18392422 | 0.79 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
chr6_+_27100811 | 0.78 |
ENST00000359193.2
|
HIST1H2AG
|
histone cluster 1, H2ag |
chr19_+_50169081 | 0.76 |
ENST00000246784.3
|
BCL2L12
|
BCL2-like 12 (proline rich) |
chr2_+_90192768 | 0.74 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr17_-_19651654 | 0.71 |
ENST00000395555.3
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr17_-_19651668 | 0.70 |
ENST00000494157.2
ENST00000225740.6 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr5_+_2752258 | 0.68 |
ENST00000334000.3
|
C5orf38
|
chromosome 5 open reading frame 38 |
chr16_+_3019309 | 0.68 |
ENST00000576565.1
|
PAQR4
|
progestin and adipoQ receptor family member IV |
chr18_-_52989525 | 0.67 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr1_+_225600404 | 0.65 |
ENST00000366845.2
|
AC092811.1
|
AC092811.1 |
chr19_-_47291843 | 0.64 |
ENST00000542575.2
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr16_-_30107491 | 0.64 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chrX_+_12993202 | 0.64 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
chr16_+_3019246 | 0.63 |
ENST00000318782.8
ENST00000293978.8 |
PAQR4
|
progestin and adipoQ receptor family member IV |
chr16_+_3019552 | 0.63 |
ENST00000572687.1
|
PAQR4
|
progestin and adipoQ receptor family member IV |
chr17_+_72426891 | 0.63 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr6_+_26124373 | 0.62 |
ENST00000377791.2
ENST00000602637.1 |
HIST1H2AC
|
histone cluster 1, H2ac |
chr19_+_17858509 | 0.62 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
chr1_+_32538492 | 0.61 |
ENST00000336294.5
|
TMEM39B
|
transmembrane protein 39B |
chr2_+_220143989 | 0.61 |
ENST00000336576.5
|
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2 |
chr14_-_107283278 | 0.60 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr14_-_23446003 | 0.60 |
ENST00000553911.1
|
AJUBA
|
ajuba LIM protein |
chr19_+_42788172 | 0.60 |
ENST00000160740.3
|
CIC
|
capicua transcriptional repressor |
chr11_-_62359027 | 0.59 |
ENST00000494385.1
ENST00000308436.7 |
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific |
chr12_+_122064673 | 0.59 |
ENST00000537188.1
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
chr19_+_50169216 | 0.58 |
ENST00000594157.1
ENST00000600947.1 ENST00000598306.1 |
BCL2L12
|
BCL2-like 12 (proline rich) |
chr6_+_43139037 | 0.58 |
ENST00000265354.4
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor) |
chr11_+_74699942 | 0.58 |
ENST00000526068.1
ENST00000532963.1 ENST00000531619.1 ENST00000534628.1 ENST00000545272.1 |
NEU3
|
sialidase 3 (membrane sialidase) |
chrX_-_48776292 | 0.58 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
chr19_-_40931891 | 0.58 |
ENST00000357949.4
|
SERTAD1
|
SERTA domain containing 1 |
chr19_+_17337007 | 0.57 |
ENST00000215061.4
|
OCEL1
|
occludin/ELL domain containing 1 |
chr2_-_219906220 | 0.55 |
ENST00000458526.1
ENST00000409865.3 ENST00000410037.1 ENST00000457968.1 ENST00000436631.1 ENST00000341552.5 ENST00000441968.1 ENST00000295729.2 |
CCDC108
|
coiled-coil domain containing 108 |
chr22_+_43011247 | 0.54 |
ENST00000602478.1
|
RNU12
|
RNA, U12 small nuclear |
chr11_-_62369291 | 0.53 |
ENST00000278823.2
|
MTA2
|
metastasis associated 1 family, member 2 |
chr11_+_110225855 | 0.53 |
ENST00000526605.1
ENST00000526703.1 |
RP11-347E10.1
|
RP11-347E10.1 |
chr6_+_151358048 | 0.52 |
ENST00000450635.1
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr19_-_44123734 | 0.51 |
ENST00000598676.1
|
ZNF428
|
zinc finger protein 428 |
chr2_+_220144052 | 0.51 |
ENST00000425450.1
ENST00000392086.4 ENST00000421532.1 |
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2 |
chr19_-_46088068 | 0.51 |
ENST00000263275.4
ENST00000323060.3 |
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
chr15_+_67458357 | 0.51 |
ENST00000537194.2
|
SMAD3
|
SMAD family member 3 |
chr2_+_90198535 | 0.50 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chrX_-_55020511 | 0.50 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr17_+_73521763 | 0.50 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr3_-_87040259 | 0.50 |
ENST00000383698.3
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr9_-_140196703 | 0.48 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr15_-_41166414 | 0.48 |
ENST00000220507.4
|
RHOV
|
ras homolog family member V |
chr11_+_74699703 | 0.48 |
ENST00000529024.1
ENST00000544263.1 |
NEU3
|
sialidase 3 (membrane sialidase) |
chr12_+_72080253 | 0.48 |
ENST00000549735.1
|
TMEM19
|
transmembrane protein 19 |
chrX_+_12993336 | 0.47 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
chr1_-_8000872 | 0.47 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
chr2_+_66918558 | 0.47 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr19_+_39903185 | 0.46 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
chr19_-_40791302 | 0.46 |
ENST00000392038.2
ENST00000578123.1 |
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr6_-_33679452 | 0.46 |
ENST00000374231.4
ENST00000607484.1 ENST00000374214.3 |
UQCC2
|
ubiquinol-cytochrome c reductase complex assembly factor 2 |
chr19_-_50168962 | 0.46 |
ENST00000599223.1
ENST00000593922.1 ENST00000600022.1 ENST00000596765.1 ENST00000599144.1 ENST00000596822.1 ENST00000598108.1 ENST00000601373.1 ENST00000595034.1 ENST00000601291.1 |
IRF3
|
interferon regulatory factor 3 |
chr20_+_34556488 | 0.46 |
ENST00000373973.3
ENST00000349339.1 ENST00000538900.1 |
CNBD2
|
cyclic nucleotide binding domain containing 2 |
chr16_-_75285380 | 0.46 |
ENST00000393420.6
ENST00000162330.5 |
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr10_+_24528108 | 0.46 |
ENST00000438429.1
|
KIAA1217
|
KIAA1217 |
chr14_-_23446021 | 0.45 |
ENST00000553592.1
|
AJUBA
|
ajuba LIM protein |
chr12_-_7245018 | 0.44 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr1_+_167298281 | 0.44 |
ENST00000367862.5
|
POU2F1
|
POU class 2 homeobox 1 |
chr19_-_1132207 | 0.44 |
ENST00000438103.2
|
SBNO2
|
strawberry notch homolog 2 (Drosophila) |
chr1_+_59775752 | 0.43 |
ENST00000371212.1
|
FGGY
|
FGGY carbohydrate kinase domain containing |
chr19_-_8373173 | 0.43 |
ENST00000537716.2
ENST00000301458.5 |
CD320
|
CD320 molecule |
chr19_+_11466167 | 0.43 |
ENST00000591608.1
|
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
chr14_+_103573853 | 0.42 |
ENST00000560304.1
|
EXOC3L4
|
exocyst complex component 3-like 4 |
chr17_-_73127778 | 0.42 |
ENST00000578407.1
|
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr11_+_64085560 | 0.41 |
ENST00000265462.4
ENST00000352435.4 ENST00000347941.4 |
PRDX5
|
peroxiredoxin 5 |
chr9_+_136325149 | 0.41 |
ENST00000542192.1
|
CACFD1
|
calcium channel flower domain containing 1 |
chr19_+_17337406 | 0.41 |
ENST00000597836.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr12_-_56224546 | 0.40 |
ENST00000357606.3
ENST00000547445.1 |
DNAJC14
|
DnaJ (Hsp40) homolog, subfamily C, member 14 |
chr19_-_45982076 | 0.40 |
ENST00000423698.2
|
ERCC1
|
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr17_+_40118773 | 0.40 |
ENST00000472031.1
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr16_-_19897455 | 0.40 |
ENST00000568214.1
ENST00000569479.1 |
GPRC5B
|
G protein-coupled receptor, family C, group 5, member B |
chr1_+_201979645 | 0.39 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr17_+_14204389 | 0.39 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
chr18_-_46784778 | 0.39 |
ENST00000582399.1
|
DYM
|
dymeclin |
chr2_-_37068530 | 0.38 |
ENST00000593798.1
|
AC007382.1
|
Uncharacterized protein |
chr2_+_145780739 | 0.38 |
ENST00000597173.1
ENST00000602108.1 ENST00000420472.1 |
TEX41
|
testis expressed 41 (non-protein coding) |
chr12_+_14927270 | 0.37 |
ENST00000544848.1
|
H2AFJ
|
H2A histone family, member J |
chr2_-_158182105 | 0.37 |
ENST00000409925.1
|
ERMN
|
ermin, ERM-like protein |
chr5_+_2752334 | 0.37 |
ENST00000505778.1
ENST00000515640.1 ENST00000397835.4 |
C5orf38
|
chromosome 5 open reading frame 38 |
chr6_-_52628271 | 0.37 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
chr16_-_73082274 | 0.37 |
ENST00000268489.5
|
ZFHX3
|
zinc finger homeobox 3 |
chr6_+_166945369 | 0.37 |
ENST00000598601.1
|
Z98049.1
|
CDNA FLJ25492 fis, clone CBR01389; Uncharacterized protein |
chr16_+_2198604 | 0.36 |
ENST00000210187.6
|
RAB26
|
RAB26, member RAS oncogene family |
chr1_-_23886285 | 0.36 |
ENST00000374561.5
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
chr1_-_149858227 | 0.35 |
ENST00000369155.2
|
HIST2H2BE
|
histone cluster 2, H2be |
chr5_-_88120151 | 0.35 |
ENST00000506716.1
|
MEF2C
|
myocyte enhancer factor 2C |
chr11_-_62358972 | 0.35 |
ENST00000278279.3
|
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific |
chr17_+_40118805 | 0.35 |
ENST00000591072.1
ENST00000587679.1 ENST00000393888.1 ENST00000441615.2 |
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr1_+_32538520 | 0.35 |
ENST00000438825.1
ENST00000456834.2 ENST00000373634.4 ENST00000427288.1 |
TMEM39B
|
transmembrane protein 39B |
chr16_-_11730213 | 0.35 |
ENST00000576334.1
ENST00000574848.1 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr6_-_10415218 | 0.35 |
ENST00000466073.1
ENST00000498450.1 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr5_-_141030943 | 0.35 |
ENST00000522783.1
ENST00000519800.1 ENST00000435817.2 |
FCHSD1
|
FCH and double SH3 domains 1 |
chr16_-_88752889 | 0.35 |
ENST00000332281.5
|
SNAI3
|
snail family zinc finger 3 |
chr1_-_6052463 | 0.34 |
ENST00000378156.4
|
NPHP4
|
nephronophthisis 4 |
chr11_-_75917569 | 0.34 |
ENST00000322563.3
|
WNT11
|
wingless-type MMTV integration site family, member 11 |
chr12_-_100656134 | 0.34 |
ENST00000548313.1
|
DEPDC4
|
DEP domain containing 4 |
chr17_-_73127826 | 0.34 |
ENST00000582170.1
ENST00000245552.2 |
NT5C
|
5', 3'-nucleotidase, cytosolic |
chr12_+_132312931 | 0.34 |
ENST00000360564.1
ENST00000545671.1 ENST00000545790.1 |
MMP17
|
matrix metallopeptidase 17 (membrane-inserted) |
chr12_-_11150474 | 0.33 |
ENST00000538986.1
|
TAS2R20
|
taste receptor, type 2, member 20 |
chr3_-_149293990 | 0.32 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr19_-_40562063 | 0.32 |
ENST00000598845.1
ENST00000593605.1 ENST00000221355.6 ENST00000434248.1 |
ZNF780B
|
zinc finger protein 780B |
chr18_-_53089723 | 0.31 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
chr19_-_1021113 | 0.31 |
ENST00000333175.5
ENST00000356663.3 |
TMEM259
|
transmembrane protein 259 |
chr6_-_52668605 | 0.31 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
chr19_-_41903161 | 0.30 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr2_-_158182322 | 0.30 |
ENST00000420719.2
ENST00000409216.1 |
ERMN
|
ermin, ERM-like protein |
chr17_+_40118759 | 0.30 |
ENST00000393892.3
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr19_-_893200 | 0.29 |
ENST00000269814.4
ENST00000395808.3 ENST00000312090.6 ENST00000325464.1 |
MED16
|
mediator complex subunit 16 |
chr17_-_46682321 | 0.29 |
ENST00000225648.3
ENST00000484302.2 |
HOXB6
|
homeobox B6 |
chr10_-_10504285 | 0.29 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
chrX_-_106960285 | 0.28 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr19_+_17337473 | 0.27 |
ENST00000598068.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr2_+_47922958 | 0.27 |
ENST00000606499.1
|
MSH6
|
mutS homolog 6 |
chr2_-_61108449 | 0.27 |
ENST00000439412.1
ENST00000452343.1 |
AC010733.4
|
AC010733.4 |
chr12_-_7245080 | 0.27 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr22_-_17640110 | 0.27 |
ENST00000399852.3
ENST00000336737.4 |
CECR5
|
cat eye syndrome chromosome region, candidate 5 |
chr17_+_38497640 | 0.26 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
chr20_+_33292068 | 0.26 |
ENST00000374810.3
ENST00000374809.2 ENST00000451665.1 |
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
chr14_-_68283291 | 0.26 |
ENST00000555452.1
ENST00000347230.4 |
ZFYVE26
|
zinc finger, FYVE domain containing 26 |
chr19_-_50169064 | 0.25 |
ENST00000593337.1
ENST00000598808.1 ENST00000600453.1 ENST00000593818.1 ENST00000597198.1 ENST00000601809.1 ENST00000377139.3 |
IRF3
|
interferon regulatory factor 3 |
chr5_+_140593509 | 0.25 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chr18_-_53089538 | 0.25 |
ENST00000566777.1
|
TCF4
|
transcription factor 4 |
chr12_+_7053172 | 0.23 |
ENST00000229281.5
|
C12orf57
|
chromosome 12 open reading frame 57 |
chr7_+_27282319 | 0.23 |
ENST00000222761.3
|
EVX1
|
even-skipped homeobox 1 |
chr20_+_816695 | 0.23 |
ENST00000246100.3
|
FAM110A
|
family with sequence similarity 110, member A |
chr19_-_3971050 | 0.23 |
ENST00000545797.2
ENST00000596311.1 |
DAPK3
|
death-associated protein kinase 3 |
chr1_-_117021430 | 0.23 |
ENST00000423907.1
ENST00000434879.1 ENST00000443219.1 |
RP4-655J12.4
|
RP4-655J12.4 |
chr1_+_6052700 | 0.23 |
ENST00000378092.1
ENST00000445501.1 |
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr18_-_52989217 | 0.23 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr17_+_43213004 | 0.23 |
ENST00000586346.1
ENST00000398322.3 ENST00000592162.1 ENST00000376955.4 ENST00000321854.8 |
ACBD4
|
acyl-CoA binding domain containing 4 |
chr19_+_11466062 | 0.22 |
ENST00000251473.5
ENST00000591329.1 ENST00000586380.1 |
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
chr6_+_155538093 | 0.22 |
ENST00000462408.2
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2 |
chr20_-_39995467 | 0.22 |
ENST00000332312.3
|
EMILIN3
|
elastin microfibril interfacer 3 |
chr19_+_19144384 | 0.22 |
ENST00000392335.2
ENST00000535612.1 ENST00000537263.1 ENST00000540707.1 ENST00000541725.1 ENST00000269932.6 ENST00000546344.1 ENST00000540792.1 ENST00000536098.1 ENST00000541898.1 ENST00000543877.1 |
ARMC6
|
armadillo repeat containing 6 |
chr15_-_89456630 | 0.22 |
ENST00000268150.8
|
MFGE8
|
milk fat globule-EGF factor 8 protein |
chr17_-_70417365 | 0.21 |
ENST00000580948.1
|
LINC00511
|
long intergenic non-protein coding RNA 511 |
chr17_+_42925270 | 0.21 |
ENST00000253410.2
ENST00000587021.1 |
HIGD1B
|
HIG1 hypoxia inducible domain family, member 1B |
chr6_+_26158343 | 0.21 |
ENST00000377777.4
ENST00000289316.2 |
HIST1H2BD
|
histone cluster 1, H2bd |
chr12_-_57328187 | 0.21 |
ENST00000293502.1
|
SDR9C7
|
short chain dehydrogenase/reductase family 9C, member 7 |
chr22_-_24096562 | 0.21 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr11_-_34379546 | 0.21 |
ENST00000435224.2
|
ABTB2
|
ankyrin repeat and BTB (POZ) domain containing 2 |
chr17_-_3794021 | 0.20 |
ENST00000381769.2
|
CAMKK1
|
calcium/calmodulin-dependent protein kinase kinase 1, alpha |
chr16_-_74808710 | 0.20 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
chr2_-_166930131 | 0.20 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr14_-_107219365 | 0.20 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr15_+_91478493 | 0.20 |
ENST00000418476.2
|
UNC45A
|
unc-45 homolog A (C. elegans) |
chr4_-_99578789 | 0.20 |
ENST00000511651.1
ENST00000505184.1 |
TSPAN5
|
tetraspanin 5 |
chr14_-_51297360 | 0.20 |
ENST00000496749.1
|
NIN
|
ninein (GSK3B interacting protein) |
chr15_-_64995399 | 0.20 |
ENST00000559753.1
ENST00000560258.2 ENST00000559912.2 ENST00000326005.6 |
OAZ2
|
ornithine decarboxylase antizyme 2 |
chr3_-_178969403 | 0.19 |
ENST00000314235.5
ENST00000392685.2 |
KCNMB3
|
potassium large conductance calcium-activated channel, subfamily M beta member 3 |
chr6_+_10585979 | 0.19 |
ENST00000265012.4
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
chr21_-_36260980 | 0.19 |
ENST00000344691.4
ENST00000358356.5 |
RUNX1
|
runt-related transcription factor 1 |
chr6_+_143999185 | 0.19 |
ENST00000542769.1
ENST00000397980.3 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr7_-_27183263 | 0.19 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 1.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.2 | 1.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 1.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.6 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.2 | 0.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 1.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 19.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 18.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.4 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 1.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 1.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 1.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.5 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:2000111 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.8 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.1 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.2 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.0 | 0.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 1.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 1.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 2.2 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.5 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 0.1 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 40.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.0 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.0 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.0 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.2 | 1.1 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 1.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.6 | GO:0010736 | serum response element binding(GO:0010736) |
0.1 | 0.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.3 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.1 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 38.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.7 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 41.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |